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BACKGROUND: Fetal exposure to maternal smoking during pregnancy is associated with the development of noncommunicable diseases in the off-
spring. Maternal smoking may induce such long-term effects through persistent changes in the DNA methylome, which therefore hold the potential to
be used as a biomarker of this early life exposure. With declining costs for measuring DNA methylation, we aimed to develop a DNA methylation
score that can be used on adolescent DNA methylation data and thereby generate a score for in utero cigarette smoke exposure.
METHODS:We used machine learning methods to create a score reflecting exposure to maternal smoking during pregnancy. This score is based on pe-
ripheral blood measurements of DNA methylation (Illumina’s Infinium HumanMethylation450K BeadChip). The score was developed and tested in
the Raine Study with data from 995 white 17-y-old participants using 10-fold cross-validation. The score was further tested and validated in independ-
ent data from the Northern Finland Birth Cohort 1986 (NFBC1986) (16-y-olds) and 1966 (NFBC1966) (31-y-olds). Further, three previously pro-
posed DNA methylation scores were applied for comparison. The final score was developed with 204 CpGs using elastic net regression.
RESULTS: Sensitivity and specificity values for the best performing previously developed classifier (“Reese Score”) were 88% and 72% for Raine,
87% and 61% for NFBC1986 and 72% and 70% for NFBC1966, respectively; corresponding figures using the elastic net regression approach were
91% and 76% (Raine), 87% and 75% (NFBC1986), and 72% and 78% for NFBC1966.
CONCLUSION:We have developed a DNA methylation score for exposure to maternal smoking during pregnancy, outperforming the three previously
developed scores. One possible application of the current score could be for model adjustment purposes or to assess its association with distal health
outcomes where part of the effect can be attributed to maternal smoking. Further, it may provide a biomarker for fetal exposure to maternal smoking.
https://doi.org/10.1289/EHP6076
Introduction
Fetal exposure to maternal smoking during pregnancy increases
the risk that the offspring will develop noncommunicable dis-
eases (NCDs) (Agrawal et al. 2010; Bhattacharya et al. 2014;
DiFranza et al. 2004; Hofhuis et al. 2003; Oken et al. 2005;
Wakschlag et al. 2002; Wiklund et al. 2019). On average, 6% of
the global female population are still smokers, although with a
high degree of variability across countries (e.g., due to differen-
ces in the social and educational contexts, laws, and cultural fac-
tors), according to the WHO report on global tobacco epidemic
2017 (WHO 2017). A 2017 paper describing the smoking rates in
Australia and Finland among other countries reported the smok-
ing rates among young pregnant women are stagnant, despite the
overall decrease in smoking rates (Reitan and Callinan 2017).
A meta-analysis by Oken et al. including 14 studies showed
that offspring of mothers who smoked during gestation had a
pooled adjusted odds ratio (OR) of 1.50 [95% confidence interval
(CI): 1.36, 1.65] for the development of obesity (Oken et al.
2008). Timmermans et al. examined the association between
maternal smoking during pregnancy and lower birth weight and
the association between maternal smoking during pregnancy and
higher weight gain and childhood overweight in the offspring
(Timmermans et al. 2014). They showed that exposure to mater-
nal smoking during pregnancy associated with an adjusted OR of
3.72 (95% CI: 1.33, 10.4) for the offspring being in the 85th BMI
percentile (Timmermans et al. 2014).
The mechanisms through which maternal smoking may influ-
ence the health of the offspring have been suggested to involve the
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altered epigenetic regulation of genes. Epigenetics is the general
term for changes to the DNA that are heritable through cell division
and that relate to gene accessibility rather than DNA sequence
changes (Goldberg et al. 2007). There are many different epigenetic
mechanisms that can affect or alter gene accessibility, such as chro-
matin structural changes, histone modification or DNAmethylation
(Goldberg et al. 2007). Many studies have shown that maternal
smoking during pregnancy is associated with highly reproducible
and specific changes in differentially methylated cytosine-
phosphate-guanine (CpG) base pairs in newborns (Joubert et al.
2016), children (Rzehak et al. 2016), young adults (Lee et al. 2015),
and middle-age adults (Sun et al. 2013). In a meta-analysis with
combined sample size of 6,685 newborns and 3,187 older children,
2,965 (FDR corrected, 568 after Bonferroni correction) differen-
tially methylated CpGs in the offspring were associated with mater-
nal smoking during pregnancy (Joubert et al. 2016). This included
CpGswithin AHRR (aryl-hydrocarbon receptor repressor),MYO1G
(Myosin 1G), CYP1A1 (Cytochrome P450 Family 1 Subfamily A
Member 1), GFI1 (Growth Factor Independent 1 Transcriptional
Repressor) and CNTNAP2 (Contactin-associated protein-like 2)
(Rotroff et al. 2016; Rzehak et al. 2016; Tehranifar et al. 2018).
These genes are associated with cancer development, detoxification
of xenobiotics (AHRR) (Esser 2012), and adult body mass index
(BMI) (GFI1) (Parmar et al. 2018) and suggest a possible epigenetic
mechanism linking fetal exposure tomaternal smoking during preg-
nancywith diseases in the offspring. Critically, Joubert et al. showed
that the same CpGs were associated with fetal smoke exposure in
cord blood, as well as in whole blood from 5-y-olds (Rzehak et al.
2016), and our own research suggests that fetal smoke exposure
may induce persistent changes to the DNAmethylome still detecta-
ble inmiddle age (Wiklund et al. 2019).
Machine learning is a subfield of artificial intelligence focusing
on pattern detection. Machine learning methods can be divided into
supervised and unsupervised methods. In supervised methods, labels
are known, and themodel tries to fit the data according to the label. In
unsupervisedmethods, the algorithm tries tofindclustering of similar
data points. In both approaches, the aim is to create a model—with
minimal assumptions on the data-generating process—that is gener-
alizable to an external data set. Machine learning has proven to be
useful in classification problems in medical research and diagnosis,
especially in cancer and image classification (Capper et al. 2018;
Díaz-Uriarte and Alvarez de Andrés 2006; Quraishi et al. 2015;
Schmidhuber 2015;Yoo et al. 2014).
Successful examples of implementation of machine learning in
epigenetics are Houseman’s cell counts (Houseman et al. 2012)
and Horvarth’s epigenetic age acceleration (Horvath 2013). Both
are widely adopted in the field and are based on the elastic net
regression approach (Zou andHastie 2005).
In light of that success, we applied machine learning methods to
develop a DNA methylation score in adolescents and adults as a
proxy for fetal exposure to maternal smoking. Similar to that
described by Reese et al. (2017), we aimed to generate a score that
could be applied to studies usingHumanMethylation450K and EPIC
BeadChip (Illumina) DNAmethylation data. In comparison with the
score by Reese et al. we have extended the DNA methylation score
to older ages, including adolescence and adulthood. In data sets with-
out information onmaternal smoking during pregnancy, establishing
and validating the score would enable its implementation in adjust-
ing epigenome-wide DNA methylation association studies for this
important early-life exposure. It may also serve as covariate to any
model in more conventional epidemiological studies to adjust for
possible confounding by maternal smoking in the absence of the
measure.With reducing costs forDNAmethylation arrays, the avail-
ability of such aDNAmethylation score would be a valuable tool for
epidemiological studies in disease pathways.
Methods
Studies
The Raine Study. The study design and initial characteristics of
the Raine Study have been previously described (Newnham et al.
1993). From 1989 to 1991, a total of 2,900 pregnant women were
enrolled. This included multiparous pregnancies. Recruitment
took place at King Edward Memorial Hospital and surrounding
private hospitals. The 2,868 live births have been followed up at
1, 2, 3, 5, 8, 10, 14 and 17 years during which anthropometric
(e.g., height, weight, skinfolds), clinical, and biochemical data
have been collected. Ethics approval for conducting the epige-
netics analysis at the 17-y follow-up was given by the Human
Ethics Committee of the University of Western Australia.
Institutional ethics approval has been obtained through the
University of Western Australia (approval numbers: RA/4/1/
6613, 1214-EP, RA-4-1-2646). Informed and written consent
was provided by the participants and their parents or legal guardi-
ans. The present analyses included 995 participants that were of
white ethnicity.
The Northern Finland Birth Cohort 1986 (NFBC1986). The
NFBC1986 consists of 99% of all children who were born in the
provinces of Oulu and Lapland in northern Finland between
1 July 1985 and 30 June 1986 (Järvelin et al. 1993). There were
9,432 live-born individuals who entered the study. At the age of
16 y, those living still in Finland (n=9,215) were invited to par-
ticipate in a follow-up study, including a clinical examination.
Overall, 7,344 participants attended the study in the year 2001/
2002, of which 5,654 completed the postal questionnaire, com-
pleted the clinical examination, provided a blood sample, and
gave written informed consent (parents and children). Approval
for the studies was granted by the ethics committee of the
Northern Ostrobothnia Hospital District in Oulu, Finland, in ac-
cordance with the Declaration of Helsinki.
The Northern Finland Birth Cohort (NFBC1966). The
NFBC1966 is a prospective follow-up study of children from the
two northernmost provinces of Finland (Rantakallio 1988). Of all
women in this region with expected delivery dates in 1966, 96%
were recruited through maternity health centers (12,058 live births).
All individuals still living in northern Finland or the Helsinki area
(n=8,463) were contacted and invited for clinical examination
when they turned 31 years of age (Järvelin et al. 2004). A total of
6,007 participants attended the clinical examination. DNA was
extracted from blood samples given at the clinical examination
(5,753 samples available). The samples were selected to resemble
the original study cohort (Järvelin et al. 2004). An informed consent
for the use of the data includingDNAwas obtained from all subjects
and approval for the study was granted by the ethics committee of
the Northern Ostrobothnia Hospital District in Oulu, Finland, in ac-
cordancewith theDeclaration ofHelsinki.
DNA methylation profiling: the Raine Study. DNA
methylation was measured in peripheral whole blood samples
from participants at age 17 y using the Illumina Infinium
HumanMethylation450K BeadChip. Venous blood samples were
taken by phlebotomists after an overnight fast. Samples were stored
at −80C (176°F) until analysis. Processing of the Illumina
Infinium HumanMethylation450K BeadChips was carried out by
the Centre for Molecular Medicine and Therapeutics (CMMT)
(http://www.cmmt.ubc.ca). We excluded three samples as outliers
and one sample for biological sex inconsistency, because this might
be indicative of a sample mix-up. Outliers were defined by the R
packages shinyMethyl (version 1.22.0, Bioconductor) (Fortin and
Hansen 2014) and MethylAid (version 1.22.0, Bioconductor) (Van
Iterson et al. 2014) as samples that did not cluster together with the
rest. Annotation of the CpG to the nearest genewas performed using
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Illumina’s genome coordinates (GRCh37/hg19). DNA methylation
data of 996 white study participants on 475,429 probes were avail-
able for analysis.
DNAmethylation profiling: NFBC1986.DNAwas extracted
from all 5,654 blood samples at the 16-y follow-up. DNA methyla-
tionwas recorded on IlluminaHumanMethlation450K array for 546
randomly selected subjects at the Department of Genomics Imperial
College London (London, UK). Of those, 24 technical replicates
were excluded. A total of 18 samples did not reach a call rate of
>95% applying a detection p-value filter of 10× 10−16. We
excluded seven samples with biological sex inconsistency, no sam-
ple was outlying from the overall data structure [first principle com-
ponent (PC) score of the DNAmethylation values outside mean ± 4
standard deviations (SD)]. DNA methylation data of 517 samples
from individuals of white ethnicity with 466,290 autosomal probes
(call ratefilter 95%) eachwere available for this analysis.
DNA methylation profiling: NFBC1966. DNA methylation
at 31 years of agewasmeasured for 807 randomly selected subjects
of white ethnicity who attended the clinical examination and com-
pleted the questionnaire at both 31 and 46 years of age. For this, the
IlluminaHumanMethlation450K arraywas used at the Department
of Genomics Imperial College London. For DNA methylation
marker calling we used a detection p-value threshold of <10−16. A
call rate filter of 95%was applied to all autosomal Illumina probes,
yielding 459,378 probes for association testing. Due to lowmarker
call rate (<95%), 67 samples were excluded. Seven samples were
excluded for biological sex inconsistency and one sample for glob-
ally outlying DNA methylation values (first PC score of the DNA
methylation values outsidemean ±4).
For all studies, we used the rawmethylation betas without plate
normalization because normalization methods might introduce
bias into the model for the machine learning approach by changing
the variance and residual structure of the DNA methylation data.
This approach might also improve the application of the score to
different data sets (Reese et al. 2017).
Smoking variables: the Raine Study. Mothers reported
smoking behavior in questionnaires administered at the 18th and
34th week of gestation. Maternal smoking during pregnancy was
coded as “yes” vs. “no” in regard to smoking during pregnancy,
based on a combination of the categorical variables for the number
of cigarettes smoked daily at 18 and 34 wk of gestation. In a previ-
ous epigenome-wide association study on the Raine Study data set,
we did not find any differences between the CpGs associated with
in utero smoke exposure at 18 wk and at 34 wk (Rauschert et al.
2019). To not sacrifice sample size, we decided to use the com-
bined time points as any smoking, as described above.
We also present data on the number of adolescents that ever
smoked. Smoking behavior of the adolescents at 16 years of age
was self-reported in a confidential online questionnaire, and we
recoded the variable asking for cigarette consumption over the
lifetime to “(any) smoking” vs. “no smoking”.
Figure S1 showing the distribution of exposure to maternal
smoking across the plates for measurement of DNA methylation
indicates no sign of a potential batch-induced bias.
Smoking variables: NFBC1986 and NFBC1966. Information
on maternal smoking was self-reported in questionnaires by moth-
ers during pregnancy. The questions asked and possible answers,
respectively, were: Did you smoke before pregnancy? yes, no; Did
you smoke when pregnancy was discovered? Yes, No; Number of
cigarettes after the second gestational month: None, <10, 10 or
more; Mother’s smoking after the second gestational month: yes/
no. This information was recoded to a binary variable indicating
any smoking during pregnancy as opposed to no smoking during
pregnancy to harmonize the data with the Raine Study variable.
The adolescents’ own smoking in NFBC1986 and adults’
smoking in NFBC1966 were also assessed using questionnaire
data. We coded them into the category ever-smoker, which
included occasional/former smoker and never smoker.
Analysis, Model Training, and Model Selection
Overview. A flow chart of the distinct modeling steps, including a
brief description and which data was used is provided in Figure 1.
The overall aim was to identify the best-performing algorithm to
Figure 1. Flow chart for the modeling steps. This includes details of the steps undertaken in the training, testing and validation phase, as well as the data used
per step.
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identify study participants as being exposed to maternal smoking
during pregnancy based on DNA methylation data. Performance in
this context is defined as the model accuracy when compared with
the known information of exposure tomaternal smoking during preg-
nancy. Tomeasure accuracy,we focused onCohen’s κ to identify the
best model in this study. First, we split the Raine Study data into
training and test set; then we applied 11 different machine learning
algorithms to the training data to make a preselection of best-
performing algorithms. The four best-performing models were taken
forward for further refinement of the model parameters. Finally, the
best-performingmodelwas selected based onCohen’s κ.
Machine learning models. To check for the performance of
different algorithms as defined in the previous paragraph, we
derived scores for the exposure to maternal smoking during preg-
nancy from several different models after training with default set-
tings for the model parameters in the statistical packages. The
exact R code used for this can be found in Supplement S1. This was
carried out to provide an overview of which methods to focus on
for further modeling. There is no standard method of selecting
machine learning algorithms. Some models are more suited for
specific tasks than others, and a good way to start is to systemati-
cally test different algorithms on the data set and preselect those
with the best initial performance for further training. It is advisable
to select a variety of different algorithms, such as tree-, regression-,
and clustering-based methods, because that allows for the testing
of linear and nonlinear associations in the data.
All statistical and predictive modeling was conducted using R
(version 3.5.1; R Development Core Team) and the caret package
(Kuhn 2008). The primarymodels evaluated in this studywere gra-
dient boosting machine (Friedman 2001) using the gbm package
(Ridgeway and Southworth 2013), elastic net regression (Zou and
Hastie 2005) using the glmnet package (Hastie and Qian 2014),
random forest (Breiman 2001) using the randomForest package
(Liaw and Wiener 2002), and support vector machine (Cortes and
Vapnik 1995) using e1071 (Meyer and Wien 2015). In addition,
we evaluated C5.0 (Pandya and Pandya 2015), Classification with
Bagging (Breiman 1996), linear discriminant analysis (Duda et al.
2012), k-nearest neighbor (Altman 1992), naive Bayes classifier
(Rish 2001), logistic regression, and classification and regression
trees (Breiman et al. 1984), which were applied by setting the caret
variable “method” to C5.0, treebag, lda, knn, nb, glm, and rpart,
respectively. All the evaluated models other than k-nearest neigh-
bor are supervisedmachine learningmodels.
Variable preselection. Overfitting in the variable selection
when using the training data for that step was accounted for by
selecting CpGs for the modeling process from the meta-analysis
of Joubert et al. (2016). Joubert et al. used both FDR and the
Bonferroni correction to define significant CpGs for their study.
The table we selected the CpGs from is Supplement 4, Table S3
in Joubert et al., with the column titled “Meta-Analysis of sus-
tained smoking and newborn methylation adjusted for cell type.”
We decided to consider an arbitrary p<0:00001 for CpGs to be
included in the modeling, which is in-between the FDR and
Bonferroni threshold. We acknowledge that linear models can
detect some relevant associations in the data but believe restrict-
ing the selection to only Bonferroni p-values limits the possibility
to identify nonlinear associations using machine learning model-
ing. Including all ∼ 450,000 variables would technically be pos-
sible, but this would be computationally very expensive in terms
of time and resources. Hence, our preselection process resulted in
the inclusion of 1,511 CpGs.
As the aim of a predictive model is to be as parsimonious as
possible, we excluded the highly correlated variables for the elas-
tic net regression model, retaining only the CpGs that retain most
of the information based on correlation structures of the data.
This was done by examining the pairwise correlation structures
of the CpGs in the Raine Study data before splitting it into train-
ing and test set. Given two CpGs were correlated with an
R2 > 0:75, we removed the CpG with the largest mean absolute
correlation and thereby reduced multicollinearity issues. For this
we used the R function findCorrelation (Kuhn 2008). In total,
267 CpGs were removed from the initial set of 1,511 CpGs
because they had correlation coefficients >0:75 with at least one
other CpG, leaving 1,244 CpGs for analysis (Table S1). The tree-
based and support vector models are not as vulnerable to corre-
lated data as the linear regression-based model; hence, all 1,511
CpGs were used for those.
Fitting method. We created the smoking score based on the
study by Reese et al. using the exact coefficients and CpGs they
identified with their LASSO approach (Reese et al. 2017). Briefly,
to retrieve the score, one needs to multiply the CpG methylation
values with the respective coefficient provided by Reese et al. in
their supplement, Tables S1, and then add up the results from all 28
CpGs. The R code used to calculate the Reese score exemplified in
the Raine Study, is provided in Supplement 1.
Richmond et al. describe two different scores for exposure to
maternal smoking during pregnancy (Richmond et al. 2018). One
score was created based on 568 CpGs from cord blood methyla-
tion data, and a second score used 19 CpGs from adult methyla-
tion data from the Avon Longitudinal Study of Parents and
Children (ALSPAC) (Joubert et al. 2016; Richmond et al. 2018).
Richmond et al. describe the calculation of the score as multiply-
ing the model coefficients from the Joubert et al. meta-analysis of
an EWAS (Epigenome Wide Association Study) for maternal
smoking during pregnancy with the CpG methylation betas
(Joubert et al. 2016). For that, the Supplement 4, Table S3, of the
Richmond et al. publication is required. Hence, we identified
the CpGs required for the score creation per Richmond et al. in
the Raine Study, NFBC1966, and NFBC1986 and multiplied the
individual participants DNA methylation values with the respec-
tive coefficient from the Joubert et al. study. For the 568 CpG
score, the column titled “Meta-Analysis of sustained smoking
and newborn methylation adjusted for cell type” is used, and for
the 19 CpG score, the column “Meta-Analysis of sustained smok-
ing and methylation in older children”.
The random forest algorithm proposed by Breiman (2001) is a
decision-tree–based algorithm. Rather than a single decision tree,
this algorithm uses an ensemble approach. Every tree is created by
only using a bootstrapped sample of the entire data. A second step
of randomness is added for each split by selecting only a random
subset of all predictive variables. Thismeans, random forest imple-
ments both bagging (a method to combine multiple unstable learn-
ers, like decision trees, to gain more stable predictions) and
randomvariable selection to build the trees, which leads to low cor-
relation between the trees in the forest. For the purpose of this
study, we set the tuneLength variable in the caret model to 20,
which means a maximum of 20 different settings for the random
forest parameters are evaluated. The following settings for the pa-
rameter mtry (number of input variables at each split) were tested:
2, 3, 5, 7, 10, 14, 19, 27, 38, 53, 74, 102, 142, 198, 275, 382, 530,
736, 1,023. For random forest, the caret package defaults the num-
ber of trees to 500 because the algorithm has been shown to plateau
in its performance around this value.
The gradient boosting machine algorithm is also a tree-based
method (Friedman 2002). Gradient boosting machines grow trees
sequentially and try to improve on those trees that show weak
predictions, making the method useful in cases of imbalanced
data, as in this study. The parameters that can be tuned in a gradi-
ent boosting machine are minimum observations per node, num-
ber of trees and interaction depth [the number of splits to be
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performed on a tree (starting from a single node)]. The following
values and all their combinations were tested: All values from 1
to 20 for interaction depth, the minimum number of observations
per node were kept at the caret default of 10, and the number of
trees was tested in steps of 50 from 50 to 1,000.
The support vector machine (SVM) algorithm uses a subset
of data points as so-called support vectors (Cortes and Vapnik
1995). In a two-dimensional case, support vectors are those data
points that are closest to the line indicating the greatest separation
between two classes. For the linear version of this model, the pa-
rameter C can be tuned. Also known as Cost, this parameter
determines the possible misclassifications that are allowed.
Simply speaking, it imposes an error penalty to the model. That
means, the higher the value of C, in theory, the less likely it
should be that the SVM algorithm will misclassify the data. In
our tuning step, with tuneLength set to 20, the following values
of C were tested: 0.00, 0.01, 0.05, 0.10, 0.25, 0.50, 0.75, 1.00,
1.25, 1.50, 1.75, 2.00, and 5.00.
The code and the final models to use the three models above
to create the score are available in Supplement 1 and require the
caret package function predict.
The fourth model tested was elastic net regression (Zou and
Hastie 2005). This model is a logistic regression-based model,
that allows to specify two parameters: lambda and alpha. The
model does not only fit the data, as in a logistic regression model,
but it also performs variable selection. For this, the penalty pa-
rameter lambda can be tuned, which, based on its size, will penal-
ize uninformative variables more. The alpha parameter can be set
to 0, 1 or any integer in between, where 1 means LASSO regres-
sion, as in the Reese et al. study. There, the model strictly drops
uninformative or correlated variables. The setting 0 for alpha
does not perform variable selection but rather calculates weights
for all variables, based on their importance for the classification.
Elastic net regression keeps the alpha value between 0 and 1,
which is a mix of both options described above; it will perform
feature selection, but in the case of correlated variables that are
both potentially meaningful for the classification, it will not ran-
domly select one of the two, like LASSO.
With tuneLength of 20, the following parameter settings and all
their combinations were tested: alpha of 0.10, 0.1473684, 0.1947368,
0.2421053, 0.2894737, 0.3368421, 0.3842105, 0.4315789, 0.4789474,
0.5263158, 0.5736842, 0.6210526, 0.6684211, 0.7157895, 0.7631579,
0.8105263, 0.8578947, 0.9052632, 0.9526316, and 1.0; lambda
of 0.003785885, 0.004714173, 0.005870074, 0.007309400,
0.009101643, 0.011333339, 0.014112241, 0.017572522, 0.021881253,
0.027246473, 0.033927228, 0.042246086, 0.052604703, 0.065503224,
0.081564423, 0.101563783, 0.126466926, 0.157476249, 0.196088967,
and0.244169411.
For the final, best performing model using elastic net regression,
the coefficients for the scoring are provided in Table S2, with instruc-
tions as to how to apply the score shown in Supplement 1. Briefly, the
model can both produce a probability score (a value between 0 and 1,
with 0 meaning not exposed and 1 meaning exposed) and a binary
class (with a cutoff of 0.5; values above that fall into the “exposed”
class,whereas values below fall into the “not exposed class”). To gen-
erate the DNA-methylation risk score (ranging from 0 to 1), the steps
are as follows: a) multiply the CpG beta values by their respective
coefficients generated by elastic net regression; and b) sum these
across the 204CpGswith the provided coefficients (Table S2).
We include a guide for easy application of this score
(Supplement 1). This is taken from our R package, which is
developed on github, so anyone can apply the score via the R pro-
gramming language (https://github.com/Hobbeist/DNAsmokeR).
Of note, elastic net regression is the only machine learning
model used in this study that not only fits a predictive model but
also performs variable selection. This is why the creation of the
score requires only 204 CpGs for elastic net regression, whereas
all input CpGs are required for score creation in the other
methods.
All models were trained using an 80% training and model-
fitting subset and a 20% test subsample of the Raine Study data
(Figure 1). The 80% training and model-fitting sample was deter-
mined using stratified randomized selection to retain the ratio
between smoke exposure groups. For the training step in the 80%
subset, we applied 10-fold cross-validation with 5 repeats.
Therefore, the Raine model-fitting data set was randomly sampled
5 times into 10 groups, and for each sampling, 10 models were fit-
ted (each time the model was fitted excluding one group, and pre-
dicted values were estimated for the remaining group). The
average Cohen’s κ results of those 50modeling steps were used for
comparing and selecting the best model. All CpG values were cen-
tered and scaled for the modeling. The R code for model training
and testing of the above fourmachine learningmodels can be found
in Supplement 1.
Imbalanced data problem. Classification algorithms try to
reduce the overall error rate in classification; highly imbalanced
data sets, where the minority class is very small in comparison
with the majority class, tend to show good prediction accuracy
but an overrepresentation of classification into the majority class.
This also means, that prediction accuracy is not a feasible mea-
sure for overall classification quality. We used the following
three approaches to address this: The data set was split into train-
ing and test data, stratified by exposure to smoking, meaning the
ratio of smoke exposed to not exposed was the same in the train-
ing and test sets. To overcome the imbalance problem further, we
applied a synthetic minority oversampling technique (Chawla
et al. 2002), which outperforms oversampling the minority class
(smoke exposed in our example) or undersampling the majority
class (not exposed). In this approach, new, synthetic minority
instances are created between existing data points, based on k-
nearest neighbors.
We trained all our models on the kappa (j) metric by Cohen
(Cohen 1960; Viera and Garrett 2005). This metric compares the
observed prediction accuracy with the expected prediction accu-





where po is the observed prediction accuracy, and pe is the
expected prediction accuracy. For values between 0 and 1, 1 indi-
cates a perfect prediction. We also report sensitivity, specificity,
and area under the curve (AUC) because AUC has been estab-
lished as a model comparison measure in machine learning (Held
et al. 2016; Jin and Ling 2005).
Further, we report the Brier score as another quality measure,





fi − oið Þ2,
where N is the number of forecasts, fi is the score for participant i
and oi is the observed class: 0 for not exposed and 1 for exposed.
The Brier score is a good quality measure for a probability score
(Rufibach 2010). In terms of interpretation, values close to 0 indi-
cate very good predictive power, whereas values close to 1 indi-
cate bad performance.
Criteria for model selection. For the selection of the best
model, the quality measure of interest was Cohen’s κ (prediction
accuracy and Cohen’s κ for all models are reported in Figure S2).
Environmental Health Perspectives 097003-5 128(9) September 2020
The top four algorithms were elastic net regression, gradient
boosting machine, SVM, and random forest. Hence, we decided
to train those four models further and compare them based on
Cohen’s κ, sensitivity, specificity, and AUC. The model quality
measures sensitivity, specificity, accuracy, and AUC were
derived from the receiver operating characteristic (ROC) curve,
using the point that minimizes the distance from the ROC curve
to the top left corner, using the R packages pROC, caret and
plotROC. The caret package was used to calculate the kappa
statistic.
Final model exploration.Model quality measures and vari-
able importance. For each machine learning model, we deter-
mined the CpGs that contributed the most toward the classification
based on the absolute value of their estimated coefficients and
compared the top 20 CpGs from each model to identify CpGs that
were common across multiple models. To facilitate comparisons
across models, we derived a measure of relative importance for
each CpG by scaling the absolute value of each coefficient to the
CpG coefficient with the largest value for each model.
This was done because these variables might hold insights
into potential biological associations between maternal smoking
during pregnancy and DNA methylation in the offspring.
Significance test for ROC differences. The elastic net regres-
sion–based smoking score, the Reese score, and the Richmond
score are all continuous values that we inspect via ROC curves.
To identify whether the observed difference in the ROC-curves
and area under the ROC curves is statistically significant, we used
DeLongs test. This test is used to check whether ROC curves are
uncorrelated and is implemented in the R function roc.test (pack-
age pROC) (DeLong et al. 1988).
EPIC array sensitivity analysis. With the availability of the
newer BeadChip array “EPIC” from Illumina, we also analyzed
the performance of the score when only using the subset of CpGs
in the elastic net model that are in both the 450k and EPIC array.
In total, there are 23 elastic net score CpGs missing compared
with 450k, totalling to 181 CpGs. We performed this sensitivity
analysis only for the final best performing model, elastic net.
Results
Participants’ characteristics (Table 1) showed no significant dif-
ferences in the comparison of age, sex, adolescent smoking, and
exposure to maternal smoking between the training (n=797) and
test sets (n=198) of the Raine Study. Maternal smoking rates
were similar in the training [ratio of exposed to not exposed: 0.42
(237/560)] and test sets [0.42 (59/139)], as expected due to the
stratified split of the Raine Study into training and test sets. In
both NFBC1986 and 1966, approximately 20% of study partici-
pants were exposed to maternal smoking during pregnancy. The
NFBC cohorts had smoking rates of 34.3% at the 16-y follow-up
(NFBC1986) and 52% at the 31-y follow-up (NFBC1966). These
proportions of smokers is higher than in the Raine Study, where
the proportion of smokers at the 17-y follow-up was 21.2% in the
testing and 24% in the training set.
Machine Learning Models: Quality Measures
Taking into account that some CpGs available in the Raine Study
were not available in the NFBC studies because of post-
processing and outlier exclusion and because of the exclusion of
highly correlated CpGs to create a sparse model, as well as vari-
able selection via elastic net regression, the final number of CpGs
to create the DNA methylation score was 204 for the elastic net
(Table S2).
Scores Based on Gradient Boosting Machine, Random
Forest, and SVM
For the gradient boosting machine approach, the cross-validation
step resulted in a final model with 1,000 trees, an interaction
depth of 6, and a minimum number of observations randomly
selected per tree of 10.
The final SVM algorithm is a model with a penalization pa-
rameter C of 0.75. And finally, for the random forest: default
number of trees (500) and mtry of 198 variables.
Final DNAMethylation Score
In the Raine Study data set, gradient boosting machine outper-
formed elastic net, random forest, and SVM scores on every mea-
sure except sensitivity, which was the same for gradient boosting
machine and elastic net regression (Table 2). However, in the
NFBC data sets, elastic net outperformed gradient boosting
machine, random forest, and SVM scores for all quality measures
except sensitivity (higher for gradient boosting machine than
elastic net in all data sets, and for support vector machine in
NFBC 1966). Based on this assessment, we concluded that elastic
net regression, with an alpha of 0.1 and a lambda of 0.1264669,
had the best overall performance of the four machine learning
methods evaluated.
Table 1. Characteristics for the Raine study training and test data subset and the Northern Finland birth cohort 1986 and 1966.
Raine Study: testing Raine Study: training p NFBC1986 NFBC1966
n 198 797 478 602
Age (y) [mean (SDa)] 17.20 (0.49) 17.27 (0.61) 0.132b 16.06 (0.36) 31.01 (0.34)
Sex (%) 0.975c
Male 99 (50.0) 402 (50.4) 221 (46.2) 261 (43.4)
Female 99 (50.0) 395 (49.6) 257 (53.8) 341 (56.6)
Adolescent smoking (%)d 0.401e
Non-smoker 108 (54.5) 392 (49.2) 288 (60.3) 283 (47.0)
Ever-smoker 42 (21.2) 191 (24.0) 164 (34.3) 313 (52.0)
Missing 48 (24.2) 214 (26.9) 26 (5.4) 6 (1.0)
Maternal smoking during pregnancy (%)f 1c
Exposed 59 (29.8) 237 (29.7) 95 (19.9) 130 (21.6)
Not exposed 139 (70.2) 560 (70.3) 383 (78.7) 472 (78.4)




dAdolescent smoking status was defined as ever smoked during the lifetime vs. never smoked as based on questionnaires.
eWilcoxon Mann-Whitney U-test.
fMaternal smoking was defined as any smoking during pregnancy.
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Previous “Gold Standard” Scores
Reese et al. score. The model evaluation metrics for the Reese
score can be found in Table 2. For all metrics, including our key
metric Cohen’s κ, the elastic net regression–based score outper-
formed the Reese score in the Raine Study. However, when com-
paring the ROC curves (Figure 2), the regression elastic net–based
curve did not significantly differ from the Reese score curve for the
Raine Study based on the DeLong test (Table 3). In NFBC1986,
the sensitivity is the same between the regression elastic net and
the Reese score; however, all other model measures, including
Cohen’s κ, are better in the regression elastic net score. The
DeLong test, as indicated in Table 3, shows a significant difference
between the regression elastic net and the Reese score, with
the elastic net–based score outperforming the Reese score. And the
same is true for NFBC1966. There is no difference in sensitivity,
but all other measures show that the regression elastic net score
outperforms the Reese score.
Richmond et al. scores. For the Raine Study, the elastic net
score outperforms the Richmond score with 568 and 19 CpGs
in all model metrics. Further, as can be seen in Table 2, the
ROC curves are significantly different between the elastic net
and the Richmond based scores. The same is true for both
NFBC studies, although the specificity is slightly better for the
Richmond score with 568 CpGs in NFBC1986. Further, the
Reese score outperforms both Richmond scores in all studies,
except for the specificity in NFBC1986. Between the two
Richmond scores, the 568 CpG score performs better than the
19 CpG score in all studies.
Variable importance. Seven CpGs were included in the top 20
CpGs for each of the four machine learning models, including the
top four CpGs from the elastic net model: cg14179389 (GFI1, with
the highest coefficient for the elastic net model), cg25949550
(CNTNAP2, 94% importance relative to cg14179389), cg22132788
(MYO1G, 80% relative importance), and cg11207515 (also in
CNTNAP2, 66% relative importance) (Table S2). The remaining
CpGs included in the top 20 CpGs for all machine learning
models were cg13570656 (CYP1A1), cg17924476 (AHRR), and
cg08474748 (ANKRD31) (Tables S3–S6).
For the gradient boosting machine algorithm, the first four
CpGs were also frequently among the top CpGs in epigenome-
wide association studies: cg22132788 (MYO1G, 100% impor-
tance), cg14179389 (GFI1, 99.99% importance), cg25949550
(CNTNAP2, 80.9% importance), and cg17924476 (AHRR, 20.8%
importance).
The SVM algorithm identified CpGs in associated with
MYO1G, CNTNAP2, GFI1, CYP1A1, AHRR and FTO among the
top 10 most important variables in developing the score. Last, the
random forest algorithm chose CpGs as the top 10 most impor-
tant variables that are all frequently associated with maternal
smoking during pregnancy. Those CpGs were associated with the
genesMYO1G, CNTNAP2, GFI1, AHRR, CYP1A1 and FTO.
EPIC array sensitivity analysis. The results for applying the
elastic net score to those CpGs available in EPIC data (with 23
score CpGs missing compared with 450k, totaling to 181 CpGs for
this analysis) can be found in Supplement 1, Table S1. For all met-
rics, the elastic net score based on the 450K version of Illumina’s
BeadChip array outperforms the elastic net score using only the
181 CpGs also available on the EPIC array. The overall perform-
ance, however, is still good, with Cohen’s κ values all exceeding
0.3, with the best value in the Raine study being 0.65.
Discussion
In this study, we have developed a DNA methylation score for ex-
posure to maternal smoking during pregnancy that outperforms an
existing composite score (Reese et al. 2017), using DNA methyla-
tion probes (CpGs)measured in peripheral blood at the 17-y follow
up of the Raine Study. We believe that with declining costs for
measuring DNA methylation, such a DNA-methylation score
could be a valuable contribution to epidemiological studies and
clinical diagnostics.
To identify the most promising machine learning algorithms
for creating the score, a range of models were chosen that
Table 2.Model quality measures (sensitivity, specificity, Cohen’s κ, accuracy, AUC curve and Brier score) for the elastic net machine learning model, Reese
et al. cord blood, Richmond et al. 568 CpG, Richmond et al. 19 CpG score the gradient boosting machine, random forest and support vector machine models
that were among the four best performing models in our analysis. Results provided in this table are based on the Raine Study test data (n=198), NFBC1986
(n=478), and NFBC1966 (n=602).
Sensitivity Specificity Cohen’s κ Accuracy AUC Brier score # CpGs required
Raine Study test data set
Elastic net score 0.91 0.76 0.68 0.83 0.87 0.13 204
Gradient boosting machine 0.91 0.82 0.72 0.88 0.88 0.1 1,511
Random forest 0.87 0.73 0.58 0.83 0.83 0.17 1,511
Support vector machine 0.87 0.73 0.6 0.83 0.85 0.13 1,511
Reese score 0.88 0.72 0.6 0.83 0.85 0.21 28
Richmond score 568 CpGs 0.7 0.68 0.34 0.69 0.72 0.22 568
Richmond score 19 CpGs 0.79 0.58 0.37 0.72 0.73 0.22 19
NFBC1986
Elastic net score 0.87 0.75 0.56 0.84 0.85 0.13 204
Gradient boosting machine 0.95 0.29 0.19 0.54 0.74 0.39 1,511
Random forest 0.79 0.16 0.06 0.64 0.54 0.24 1,511
Support vector machine 0.87 0.44 0.33 0.77 0.79 0.16 1,511
Reese score 0.87 0.61 0.46 0.82 0.8 0.18 28
Richmond score 568 CpGs 0.65 0.76 0.34 0.74 0.71 0.22 568
Richmond score 19 CpGs 0.65 0.77 0.31 0.68 0.73 0.22 19
NFBC1966
Elastic net score 0.72 0.78 0.39 0.73 0.8 0.19 204
Gradient boosting machine 0.88 0.26 0.1 0.45 0.68 0.48 1,511
Random forest 0.77 0.18 0.05 0.64 0.48 0.24 1,511
Support vector machine 0.88 0.45 0.33 0.76 0.75 0.2 1,511
Reese score 0.72 0.7 0.32 0.71 0.73 0.18 28
Richmond score 568 CpGs 0.66 0.63 0.22 0.69 0.72 0.22 568
Richmond score 19 CpGs 0.61 0.72 0.23 0.63 0.73 0.22 19
Note: AUC, area under the receiver operator curve.
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performed well in similar tasks and reflect a broad range of
approaches from linear to nonlinear. We decided to further test
the performance of elastic net regression, gradient boosting,
SVM, and random forest algorithms, as they showed the best per-
formance with respect to Cohen’s κ in the algorithm selection
step and are algorithms previously used in other epigenetic pre-
dictive modeling problems (Capper et al. 2018; Horvath 2013;
Houseman et al. 2012).
Our study aimed to establish a score using only variables cre-
ated by the Illumina HumanMethylation450K BeadChip, because
this makes the score independent of any other variables that stud-
ies otherwise would need to have collected. In comparison with
more classical statistical approaches, the single aim of creating a
score is that it is as accurate as possible in differentiating individ-
uals exposed to in utero smoke from individuals not exposed to
in utero smoke, with as little input as necessary.
Further, we purposely used raw DNA methylation betas, to
avoid skewing the models based on normalization methods,
which alter the residual and variance structure of the data. This
approach also avoids the need for studies that aim to apply this
score to normalize their data in a specific way, making it simple
to apply. The main reason for doing so is that there is no gold
standard of correcting the probes from the BeadChip, and the
methods all perform slightly differently (Marabita et al. 2013).
Ideally, the same normalization method would be applied to the
training data as well as any data that applies the score. Using the
raw values overcomes the issue initially and, as shown in this
study, performs very well when applied to other studies.




Raine Study NFBC1986 NFBC1966
Elastic net vs. Reese score 0.49 0.12 0.03
Elastic net vs. Richmond young 0.00058 0.008 0.006
Elastic net vs. Richmond old 0.01 0.04 0.004
Reese vs. Richmond young 1:57× 10−6 0.23 0.43
Reese vs. Richmond old 0.002 0.67 0.47























Elastic net score: AUC 0.87
Reese score: AUC 0.85
Richmond score: AUC 0.72
























Elastic net score: AUC 0.85
Reese score: AUC 0.80
Richmond score: AUC 0.71
























Elastic net score: AUC 0.80
Reese score: AUC 0.73
Richmond score: AUC 0.72
Richmond Score: older children: AUC 0.73
NFBC66 Study
Figure 2. ROC for the four different model scores tested: elastic net regression, Reese et al. methylation score, Richmond et al. 568 CpG, and 19 CpG scores.
AUC provided for every score, applied to the Raine Study test set, NFBC1986, and NFBC1966. Note: AUC, area under the ROC; ROC, receiver operator
curve.
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In the Raine Study and NFBC1986, our score performs mod-
erately better than the Reese et al. (2017) score created from cord
blood. Reese et al. applied the LASSO penalized model rather
than an elastic net approach to derive their score. Elastic nets
have been mathematically shown to outperform LASSO regres-
sion when the number of variables is much larger than the num-
ber of cases (Zou and Hastie 2005). LASSO regression only
selects at most as many variables as there are cases, which might
not be feasible in the case of smaller sample sizes.
Nevertheless, the score by Reese et al. performs surprisingly
well in the NFBC whole blood DNA samples collected at 16 and
31 years of age, with sensitivity consistently in excess of 70%,
despite being derived based on cord blood DNA methylation.
Because the cord blood measurement is closer to the exposure to
maternal gestational smoking, the Reese et al. model might pick
up stronger associations that potentially decrease over time,
because DNA methylation has been shown to change with age
(Horvath 2013).
The good predictive capability of our score applied to both
the Raine test set and the validation study NFBC1986 (both 16
and 17 years of age) suggests that methylation could follow simi-
lar patterns across exposed and nonexposed individuals in the
same age group and still holds some structural similarities when
applied to a different age group, as in the NFBC1966.
Richmond et al. examined the relationship between maternal
smoking and DNA methylation applying two different scores
using 19 and 568 CpGs, and reported AUCs of 0.69 and 0.72,
respectively, for their population of 656 women with measure-
ments at two time points and in 230 men (Richmond et al. 2018).
The two Richmond scores both underperformed the Reese et al.
score and our own score when applied to the Raine data set and
the two NFBC data sets. The CpGs were selected based on
Bonferroni significance in association with maternal smoking,
excluding the possibility that nonsignificant associations might
still be contributing to the differences in association with mater-
nal smoke exposure, by, for example, multivariate effects, that a
linear regression model itself is not able to assess.
All four models trained in our study, independent of their
performance, selected cg22132788 (MYO1G), cg25949550
(CNTNAP2), cg14179389 (GFI1), cg11207515 (CNTNAP2),
cg13570656 (CYP1A1), cg17924476 (AHRR) and cg08474748
(ANKRD31) among the top 20 most influential variables for the
DNAmethylation score. These data concur with findings of sev-
eral studies investigating DNA methylation in different age
groups, showing that the same CpGs are differentially associ-
ated with [...] in utero exposure to maternal smoking (Joubert
et al. 2014; Richmond et al. 2015; Rzehak et al. 2016).
The final best-performing overall score of this study, the elas-
tic net, uses the FTO gene-associated cg00253658 for classifica-
tion. The associated CpG is the 20th most important CpG based
on the variable importance. This gene has previously been shown
to associate with the development of obesity (Frayling et al.
2007). There is evidence, however, that single-nucleotide poly-
morphisms in the FTO gene might rather affect expression of the
IRX3 gene, which is related to obesity (Smemo et al. 2014).
Further, methylation in the AHRR gene, with its associates CpG
cg17924476 ranked sixth in the elastic net model, was associated
with the development of eczema in boys and girls in a previous
study (Mukherjee et al. 2016). Eczema in young children is a pos-
sible precursor of asthma and allergies, highlighting the potential
association between exposure to maternal smoking during preg-
nancy and the development of asthma and allergies later in life
(Almqvist et al. 2007).
This raises the possibility of using this score as a risk score for
phenotypes associated with in utero smoke exposure such as
obesity and allergic disease (Agrawal et al. 2010; DiFranza et al.
2004; Oken et al. 2005) in future studies that may give insights into
pathways affected in fetal programming associated with maternal
smoking.
Strengths and Limitations
DNA methylation is strongly associated with exposure to mater-
nal smoking during pregnancy, as several studies have shown
(Joubert et al. 2016; Rzehak et al. 2016). Hence, it is a good start-
ing point to test which machine learning algorithms have the
potential to be used as predictive models in the future.
With availability of DNA methylation data as measured by
the Infinium HumanMethylation450K BeadChip and for all cho-
sen models, the DNA methylation variables chosen for the classi-
fication, including the parameters for each model, are easily
accessible and stated in this study. Because interpretability is im-
portant for reassurance when using in the context of clinical prac-
tice, we decided to approach the modeling with this in mind.
All maternal smoking variables were assessed via question-
naires rather than by the more objective measurement of cotinine,
which is a limitation of this study.
Further, the score was developed using whole blood DNA
methylation, which might not be the optimal sample type for spe-
cific DNA methylation and also might be affected by differences
in white blood cell counts. We did not adjust for blood cell counts
in our models, but our methylation score seemed to perform well
despite this.
The performance of the score for correctly classifying exposure
to maternal smoking during pregnancy might be influenced by cur-
rent or recent smoking by adolescent or adult offspring, which
might be more frequent in offspring exposed to maternal smoking
during pregnancy. About half of the 31-y-old NFBC1966 study
participants and over a third of the 16-y-old NFBC 1986 partici-
pants reported ever smoking. The proportion was lower in the
Raine Study (21% in the training data set) but information on
smokingwasmissing for almost one-quarter of the participants.
We used data from study participants of white ethnicity in
training, testing, and validation data; hence, its performance
needs to be confirmed in other ethnic groups. By using three dif-
ferent studies with two different age groups from culturally differ-
ent countries (Australia and Finland), however, we were able to
assess whether the models were overfit to the training study data
or generalizable. The match between the Raine Study and
NFBC1986 in terms of sex and follow-up is by chance, because
both studies were independently developed, and data collection
performed independently.
The model was created using data from the 450K version of
the Illumina HumanMethylation series and not the newer EPIC
version. The score still performed well when based only on the
181 CpGs available in the EPIC array using the coefficients in
Table S2. Further, investigators whose data are missing other
CpGs can also derive a score based on available CpGs, though
the score’s performance might differ, and the performance will
be somewhat uncertain. We did not have pyro-sequenced data
available to test how the smoking score would compare with the
score derived from the 450K BeadChip array.
Further, although using raw DNA methylation data in our
study showed very good results, future studies should systemati-
cally evaluate the effect of available normalization methods on
the DNA-methylation score.
Conclusions
Our study shows that DNA methylation in late adolescence and
early adulthood can be used to establish a score for the exposure
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to maternal smoking during pregnancy. The score was validated
externally in study populations from Finland and Australia.
We have evaluated the different machine learning approaches
by using imbalanced data specific measures (Cohen’s κ) as well
as established comparative measures such as AUC, as in similar
studies (Held et al. 2016; Jin and Ling 2005).
Our findings suggest that the score can be used by studies that
have Illumina HumanMethylation450K or EPIC data available.
As maternal smoking during pregnancy is one of the most well-
established early life variables to be strongly associated with
DNA methylation later in life, this score allows for studies that
do not have information on maternal smoking behavior during
pregnancy to account for its variance. For future studies, it might
be interesting to test the interaction of this score with other risk
factors related to maternal smoking during pregnancy.
The score combines information on DNA methylation and
early-life exposure, and potentially a means to examine associa-
tions between this score and health outcomes such as cardiometa-
bolic or respiratory diseases.
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